HCV Epidemiology & Mortality
EASL 2014: Treatment as Prevention for Drug Users Could Slash HCV Prevalence
- Details
- Category: Injection Drug Use
- Published on Sunday, 13 April 2014 00:00
- Written by Keith Alcorn
A combination of increased testing, improved linkage to care, and earlier treatment with interferon-free regimens has the potential to substantially reduce the incidence and prevalence of hepatitis C among people who inject drugs in France over the next 10 years, as well as reducing the burden of disease arising from cirrhosis over 40 years, according to a study presented at the 49th EASL International Liver Congress (EASL 2014) last week in London.
New U.S. Hepatitis C Survey Suggests Lower Prevalence, Higher Mortality
- Details
- Category: HCV Epidemiology & Mortality
- Published on Friday, 14 March 2014 00:00
- Written by Liz Highleyman
An estimated 2.7 million people in the U.S. have chronic hepatitis C, substantially lower than previous estimates, according to an analysis from the National Health and Nutrition Examination Survey(NHANES) published in the March 4 edition of Annals of Internal Medicine. This figure may be an underestimate, however, as the household survey does not include higher-risk populations including homeless and incarcerated people.
Hepatitis C Prevalence Varies Widely among U.S. Latino Populations
- Details
- Category: HCV Epidemiology & Mortality
- Published on Thursday, 16 January 2014 00:00
- Written by Albert Einstein College of Medicine
Hepatitis C occurs at different rates in different Latino and Hispanic groups in the U.S., being highest among Puerto Rican men (nearly 12%) and lowest among South American men (0.4%), according to a report in the January 13, 2014, advance edition of the Journal of Infectious Diseases.
Deaths Due to Hepatitis C Likely Undercounted
- Details
- Category: HCV Epidemiology & Mortality
- Published on Thursday, 20 February 2014 00:00
- Written by Liz Highleyman
Hepatitis C is "under-documented" on death certificates of people who die with the disease, according to a report in the February 12 advance edition of Clinical Infectious Diseases. Only about 20% of people with HCV-related chronic liver disease had this listed as a cause of death, even though a majority had evidence of moderate or advanced liver fibrosis. A related study in New York City found that people with hepatitis C were at increased risk of dying, and of dying at younger ages.
Hepatitis B and C Reduce Survival by More than 20 Years
- Details
- Category: HBV Epidemiology & Mortality
- Published on Monday, 23 December 2013 00:00
- Written by Liz Highleyman
People with chronic hepatitis B or C lived about 2 decades less on average than those who did not have these infections, and chronic viral hepatitis was the 15th leading cause of death in the U.S. in 2010, CDC researchers reported in the January 1, 2014, issue of Clinical Infectious Diseases.
More Articles...
- AASLD 2013: Viral Hepatitis Epidemics in the U.S. and California
- AASLD 2013: Viral Hepatitis Is a Leading Cause of Death Worldwide
- AASLD 2013: Expanded Hepatitis C Screening Needed for Veterans, Baby Boomers, Pregnant Women
- AASLD 2013: Veterans Study Supports CDC Recommendation to Screen Baby Boomers for Hep C
Web Design and Development by